Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 897-904

  Lin, Jr Shiuan ^a   Szaba, Frank M ^a   Kummer, Lawrence W ^a   Chromy, Brett A ^b   Smiley, Stephen T ^a  

^a TRUDEAU INSTITUTE   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; EPITOPE; LIVE VACCINE; UNCLASSIFIED DRUG; YERSINIA OUTER PROTEIN E; YERSINIA PESTIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNIZATION; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; YERSINIA PESTIS;

ACUTE DISEASE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONE CELLS; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAGUE; PNEUMONIA, BACTERIAL; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VACCINES, SUBUNIT;

EID: 79960482308     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100174     Document Type: Article

References (34)

1. Anevlavis, S., and D. Bouros. 2010. Community acquired bacterial pneumonia. Expert Opin. Pharmacother. 11: 361-374.
2. Peleg, A. Y., and D. C. Hooper. 2010. Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 362: 1804-1813.
3. Casadevall, A., and L. A. Pirofski. 2006. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv. Immunol. 91: 1-44.
4. Perry, R. D., and J. D. Fetherston. 1997. Yersinia pestis: etiologic agent of plague. Clin. Microbiol. Rev. 10: 35-66.
5. Brubaker, R. R. 2000. Yersinia pestis and bubonic plague. In The Prokaryotes, an Evolving Electronic Resource for the Microbiological Community. M. Dworkin, S. Falkow, E. Rosenberg, K.-H. Schleifer, and E. Stackebrandte, eds. Springer-Verlag, New York.
6. Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, et al; Working Group on Civilian Biodefense. 2000. Plague as a biological weapon: medical and public health management. JAMA 283: 2281-2290.
7. Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337: 677-680.
8. Wren, B. W. 2003. The yersiniae: a model genus to study the rapid evolution of bacterial pathogens. Nat. Rev. Microbiol. 1: 55-64.
9. Russell, P., S. M. Eley, S. E. Hibbs, R. J. Manchee, A. J. Stagg, and R. W. Titball. 1995. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13: 1551-1556.
10. Szaba, F. M., L. W. Kummer, L. B. Wilhelm, J. S. Lin, M. A. Parent, S. W. Montminy-Paquette, E. Lien, L. L. Johnson, and S. T. Smiley. 2009. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague. Infect. Immun. 77: 4295-4304.
11. Feodorova, V. A., and M. J. Corbel. 2009. Prospects for new plague vaccines. Expert Rev. Vaccines 8: 1721-1738.
12. Meyer, K. F., D. C. Cavanaugh, P. J. Bartelloni, and J. D. Marshall Jr. 1974. Plague immunization. I. Past and present trends. J. Infect. Dis. 129: S13-S18.
13. Welkos, S., M. L. Pitt, M. Martinez, A. Friedlander, P. Vogel, and R. Tammariello. 2002. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 20: 2206-2214. (Pubitemid 34497029)
14. Smiley, S. T. 2008. Current challenges in the development of vaccines for pneumonic plague. Expert Rev. Vaccines 7: 209-221. (Pubitemid 351357956)
15. Bashaw, J., S. Norris, S. Weeks, S. Trevino, J. J. Adamovicz, and S. Welkos. 2007. Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin. Vaccine Immunol. 14: 605-616.
16. Elvin, S. J., and E. D. Williamson. 2004. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. Microb. Pathog. 37: 177-184.
17. Smiley, S. T. 2008. Immune defense against pneumonic plague. Immunol. Rev. 225: 256-271.
18. Lin, J. S., S. Park, J. J. Adamovicz, J. Hill, J. B. Bliska, C. K. Cote, D. S. Perlin, K. Amemiya, and S. T. Smiley. 2010. TNFa and IFNg contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 29: 357-362.
19. Lin, J. S., L. W. Kummer, F. M. Szaba, and S. T. Smiley. 2011. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J. Immunol. 186: 1675-1684.
20. Motin, V. L., A. M. Georgescu, J. P. Fitch, P. P. Gu, D. O. Nelson, S. L. Mabery, J. B. Garnham, B. A. Sokhansanj, L. L. Ott, M. A. Coleman, et al. 2004. Temporal global changes in gene expression during temperature transition in Yersinia pestis. J. Bacteriol. 186: 6298-6305.
21. Porgador, A., H. F. Staats, B. Faiola, E. Gilboa, and T. J. Palker. 1997. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J. Immunol. 158: 834-841.
22. Hikono, H., J. E. Kohlmeier, K. H. Ely, I. Scott, A. D. Roberts, M. A. Blackman, and D. L. Woodland. 2006. T-cell memory and recall responses to respiratory virus infections. Immunol. Rev. 211: 119-132.
23. Hogan, R. J., E. J. Usherwood, W. Zhong, A. A. Roberts, R. W. Dutton, A. G. Harmsen, and D. L. Woodland. 2001. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166: 1813-1822.
24. Falgarone, G., H. S. Blanchard, F. Virecoulon, M. Simonet, and M. Breban. 1999. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response. J. Immunol. 162: 2875-2883. (Pubitemid 29309314)
25. Leary, S. E., K. F. Griffin, E. E. Galyov, J. Hewer, E. D. Williamson, A. Holmström, A. Forsberg, and R. W. Titball. 1999. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Microb. Pathog. 26: 159-169.
26. Andrews, G. P., S. T. Strachan, G. E. Benner, A. K. Sample, G. W. Anderson, Jr., J. J. Adamovicz, S. L. Welkos, J. K. Pullen, and A. M. Friedlander. 1999. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect. Immun. 67: 1533-1537.
27. Li, B., L. Zhou, J. Guo, X. Wang, B. Ni, Y. Ke, Z. Zhu, Z. Guo, and R. Yang. 2009. High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay. Infect. Immun. 77: 4356-4361.
28. Rosqvist, R., K. E. Magnusson, and H. Wolf-Watz. 1994. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13: 964-972. (Pubitemid 24057529)
29. Viboud, G. I., and J. B. Bliska. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59: 69-89.
30. Rüssmann, H., A. Weissmüller, G. Geginat, E. I. Igwe, A. Roggenkamp, A. Bubert, W. Goebel, H. Hof, and J. Heesemann. 2000. Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur. J. Immunol. 30: 1375-1384.
31. Rüssmann, H., E. I. Igwe, J. Sauer, W. D. Hardt, A. Bubert, and G. Geginat. 2001. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J. Immunol. 167: 357-365. (Pubitemid 32567800)
32. Wiedig, C. A., U. Kramer, S. Garbom, H. Wolf-Watz, and I. B. Autenrieth. 2005. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains. Vaccine 23: 4984-4998.
33. Trülzsch, K., T. Sporleder, R. Leibiger, H. Rüssmann, and J. Heesemann. 2008. Yersinia as oral live carrier vaccine: influence of Yersinia outer proteins (Yops) on the T-cell response. Int. J. Med. Microbiol. 298: 59-67.
34. Wang, S., J. D. Goguen, F. Li, and S. Lu. 2011. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge. Vaccine. In press.